Explore peptides & wellness compounds.

Aromatase inhibitor used off-label in men to limit conversion of testosterone to estrogen.

Erythropoietin-derived 11-amino-acid peptide studied in trials for small-fiber neuropathy.

An investigational once-weekly fixed-dose combination of an amylin analogue and a GLP-1 receptor agonist.

SERM used off-label to stimulate endogenous testosterone in men.

Once-weekly GLP-1 receptor agonist studied for type 2 diabetes.

Selective estrogen receptor modulator studied to raise testosterone while preserving fertility.

Primary estrogen hormone used in menopausal and gender-affirming hormone therapy.

GLP-1 receptor agonist studied for type 2 diabetes glycemic control.

Synthetic GnRH studied for stimulating the pituitary-gonadal axis.

Gonadotropin that mimics LH, studied for testicular function and fertility.

Recombinant 191-amino-acid human growth hormone, FDA-approved for several growth-hormone-deficiency and wasting conditions.

Gonadotropin hormone that mimics LH to stimulate testicular testosterone production.

Synthetic octapeptide studied as a gut tight-junction regulator that acts locally in the intestine.

Daily GLP-1 receptor agonist studied for diabetes and weight management.

Investigational long-acting GLP-1 receptor agonist and GIP receptor antagonist studied for obesity.

A synthetic oxyntomodulin analog that acts as a dual GLP-1 and glucagon receptor agonist.

A synthetic alpha-MSH analog that activates the MC1 receptor to increase skin pigmentation.

Oral, non-peptide small-molecule GLP-1 receptor agonist studied for weight management and type 2 diabetes.

FDA-approved semi-synthetic polysaccharide studied off-label for joint and cartilage protection.

Endogenous steroid hormone used in HRT, often to protect the uterine lining.

Melanocortin receptor agonist studied for sexual desire and arousal.

GLP-1 receptor agonist studied for glycemic control and weight management.

Mitochondria-targeting tetrapeptide that stabilizes cardiolipin in the inner membrane.

FDA-approved GHRH analog for excess abdominal fat in HIV-associated lipodystrophy.

Long-acting injectable testosterone ester used as replacement therapy in men.

Long-acting injectable testosterone ester used as replacement therapy in men.

Thymic peptide studied as an immune modulator and vaccine adjuvant.

Naturally occurring 43-amino-acid regenerative peptide with an ophthalmic drug program studied in controlled human trials.

Dual GIP/GLP-1 receptor agonist studied for diabetes and weight management.

Investigational single-molecule GLP-1 and amylin receptor agonist studied for obesity and type 2 diabetes.

Investigational monoclonal antibody blocking activin type II receptors, studied for fat loss with muscle preservation.

Synthetic gastric pentadecapeptide studied for soft-tissue and gut healing in animal models.

Investigational long-acting amylin analog studied for weight management.

Porcine-brain-derived peptide mixture studied for dementia, stroke, and TBI.

Adrenal steroid precursor to testosterone and estrogen, sold mostly as a supplement.

SERM studied for raising testosterone while preserving fertility in men.

Full-length follistatin precursor (FS344) studied for binding myostatin and activin to influence muscle-growth signaling.

Copper-binding tripeptide studied topically for skin renewal and wound healing.

Synthetic ghrelin-receptor agonist studied for growth-hormone release.

Endogenous antioxidant tripeptide central to cellular redox balance and detoxification.

Hypothalamic neuropeptide studied for reproductive-axis and sexual brain signaling.

Amino-acid derivative that shuttles fatty acids into mitochondria for energy production.

The sole human cathelicidin antimicrobial peptide with immune-modulating roles.

A topical signal peptide used in anti-aging cosmetics to influence skin matrix proteins.

A topical cosmetic matrikine peptide blend studied for the appearance of aging skin.

Orally active ghrelin-receptor agonist studied for non-pulsatile GH and IGF-1 elevation.

Coenzyme central to mitochondrial energy production whose tissue levels decline with age.

Vitamin B3-related precursors that the body converts into NAD+.

Endogenous hormone studied for bonding, intimacy, and orgasm-related effects.

An investigational injectable GLP-1/glucagon dual receptor agonist studied for obesity and fatty liver disease.

Investigational long-acting amylin analog being developed as a once-weekly injection for weight management.

Investigational triple GIP/GLP-1/glucagon receptor agonist studied for obesity.

Synthetic tuftsin-derived heptapeptide studied as a non-sedating anxiolytic.

Russian-developed ACTH(4-10) analog studied as a nootropic and neuroprotective peptide.

GHRH analog peptide that prompts the pituitary to release growth hormone.

A synthetic octapeptide studied as a topical cosmetic ingredient for the look of expression lines.

A naturally occurring dietary polyamine studied as an autophagy inducer in aging research.

Investigational dual GLP-1/glucagon receptor agonist studied for obesity and metabolic liver disease.

Investigational triple monoamine reuptake inhibitor studied for obesity.

Pentapeptide fragment of thymopoietin studied for restoring T-cell function.

Gut-derived metabolite of dietary ellagitannins studied as a mitophagy inducer for mitochondrial health.

Naturally occurring 28-amino-acid peptide studied for broad anti-inflammatory effects.

Small-molecule NNMT inhibitor researched for fat metabolism.

Experimental peptidomimetic designed to target the blood vessels supplying white fat tissue.

Synthetic growth-hormone fragment researched for fat metabolism.

A synthetic peptide studied in topical cosmetics for the look of expression lines.

Short-acting modified GHRH analog studied as a pulsatile growth-hormone stimulus.

Long-acting GHRH analog studied for sustained growth-hormone elevation.

Angiotensin IV-derived peptidomimetic studied in preclinical models for synaptogenesis.

A naturally occurring nonapeptide studied for sleep regulation, with mixed human evidence.

Senolytic peptide designed to selectively trigger apoptosis in senescent cells.

A naturally occurring human tripeptide studied in skin care in its non-copper-bound form.

Early clinically studied GHRP; ghrelin-receptor agonist with marked appetite effect.

Synthetic GHRP analog studied for growth-hormone and cardiovascular effects.

A synthetic C-terminal fragment of human growth hormone studied for fat metabolism in research settings.

Mitochondrial-derived peptide that acts as a cytoprotective and neuroprotective signal.

A truncated analog of IGF-1 studied chiefly in cell and animal models for localized growth signaling.

A long-acting synthetic analog of insulin-like growth factor 1 used chiefly as a research reagent.

Selective ghrelin-receptor agonist that stimulates a growth-hormone pulse.

A naturally occurring protein, first linked to aging in mice, studied as a longevity and cognition factor.

Alpha-MSH-derived tripeptide studied for anti-inflammatory effects in the gut and skin.

A compounded lipotropic blend combining methionine, inositol, choline, and vitamin B12.

A locally expressed IGF-1 splice variant studied in animal models for muscle repair.

Mitochondrial-derived peptide researched for metabolic regulation.

Adamantane-modified CNTF-derived tetrapeptide studied for neurogenesis and tau pathology.

A synthetic topical lipopeptide studied as an anti-inflammatory, skin-conditioning ingredient in cosmetic formulations.

A topical cosmetic peptide studied as a fibroblast-signaling ingredient in anti-aging skincare formulations.

Spadin-derived 7-residue peptide studied for antidepressant-like effects via TREK-1.

A pegylated, longer-acting form of a muscle-derived IGF-1 splice variant studied mainly in preclinical models.

A synthetic Glu-Asp-Arg tripeptide bioregulator studied in laboratory models for neuroprotection and gene-expression effects.

Upstream steroid precursor hormone sold as a supplement with limited evidence.

An experimental synthetic ERR agonist studied in animals as an "exercise mimetic" for metabolic pathways.

Synthetic peptide related to thymosin beta-4, studied for cell migration and soft-tissue recovery.

Calf-thymus peptide complex used in Russia as an immune bioregulator.

Synthetic dipeptide (Glu-Trp) derived from thymalin as a minimal immune regulator.

Zinc-dependent thymic nonapeptide involved in T-cell maturation and immune signaling.

Synthetic pineal tetrapeptide studied for telomerase activation and circadian regulation.

Non-selective melanocortin agonist associated with pigmentation and arousal effects.

Modified Selank variant engineered for improved enzymatic stability.

Chemically modified Semax variant designed for greater stability and longer action.

Arginate-salt form of the BPC-157 sequence sold for healing; lacks its own trial data.